Skip to content

SIMCERE PHARMACEUTICAL GROUP

CIK 0001384360

← back to feed
Revenue (TTM)
—
FY Dec 2012
Net Income (TTM)
¥56.96M
−68.1% YoY FY Dec 2012
EPS Diluted (TTM)
¥0.09
−94.4% YoY FY Dec 2012
Gross Margin
—
FY Dec 2012
Operating Margin
—
FY Dec 2012
Net Margin
—
FY Dec 2012
Free Cash Flow (TTM)
—
FY Dec 2012
Cash
¥209.85M
FY Dec 2012
Total Debt
¥108.47M
FY Dec 2012
Shares Outstanding
101.41M sh
FY Dec 2012

Revenue & Net Income

EPS (Diluted)

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings